Neutralizing Antibodies Are Associated with a Reduction of Interferon-β Efficacy during the Treatment of Japanese Multiple Sclerosis Patients. Sato D K, Nakashima I, Fukazawa T, Shimizu Y, Tomizawa Y, Yokoyama K, Misu T, Creeke PI, Farrell R, Giovannoni G, et al. Tohoku J Exp Med. 2012; 228(2):85-92. PMID: 22976494. Abstract CommentRecommendBookmarkWatch